The Multicenter Cancer of Pancreas Screening Study: Impact on Stage and SurvivalMohamad Dbouk, Michael Goggins, Bryson W. Katona et al.|Journal of Clinical Oncology|2022Cited by 222
Repurposing Itraconazole as a Treatment for Advanced Prostate Cancer: A Noncomparative Randomized Phase II Trial in Men With Metastatic Castration-Resistant Prostate CancerEmmanuel S. Antonarakis, Michael A. Carducci, Janet Mendonca et al.|The Oncologist|2013Cited by 178
Major Histocompatibility Mismatch and Donor Choice for Second Allogeneic Bone Marrow TransplantationPhilip Imus, Javier Bolaños‐Meade, Amanda L. Blackford et al.|Biology of Blood and Marrow Transplantation|2017Cited by 59
Prospective, Single-Arm Trial Evaluating Changes in Uptake Patterns on Prostate-Specific Membrane Antigen–Targeted <sup>18</sup>F-DCFPyL PET/CT in Patients with Castration-Resistant Prostate Cancer Starting Abiraterone or EnzalutamideKatherine Zukotynski, Steven P. Rowe, Urban Emmenegger et al.|Journal of Nuclear Medicine|2021Cited by 52
Blinatumomab in Combination with Immune Checkpoint Inhibitors of PD-1 and CTLA-4 in Adult Patients with Relapsed/Refractory (R/R) CD19 Positive B-Cell Acute Lymphoblastic Leukemia (ALL): Preliminary Results of a Phase I StudyJonathan Webster, Ivana Gojo, Marlise R. Luskin et al.|Blood|2018Cited by 50